{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-049390-2024-08-23T13:01:14+01:00",
    "date": "2024-08-23T13:01:14+01:00",
    "ocid": "ocds-h6vhtk-049390",
    "initiationType": "tender",
    "tender": {
        "id": "WT2024-11, WT2024-12, WT2024-13",
        "legalBasis": {
            "id": "32014L0024",
            "scheme": "CELEX"
        },
        "title": "NOVARTIS PHARMACEUTICALS UK LTD (WT) - WT2024-11, WT2024-12, WT2024-13 - RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets, SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300 mg in 2mLInjections",
        "status": "complete",
        "classification": {
            "scheme": "CPV",
            "id": "33600000",
            "description": "Pharmaceutical products"
        },
        "mainProcurementCategory": "goods",
        "description": "Supply of RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets to meet clinical need in the Western Trust until 15/08/2027. Supply of SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300mg in 2mL Injections to meet clinical need in the Western Trust until 03/08/2025.",
        "lots": [
            {
                "id": "1",
                "description": "Supply of RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets to meet clinical need in the Western Trust until 15/08/2027. Supply of SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300mg in 2mL Injections to meet clinical need in the Western Trust until 03/08/2025.",
                "awardCriteria": {
                    "criteria": [
                        {
                            "type": "price"
                        }
                    ]
                },
                "hasOptions": false,
                "status": "cancelled"
            }
        ],
        "items": [
            {
                "id": "1",
                "deliveryAddresses": [
                    {
                        "region": "UKN"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "procurementMethod": "limited",
        "procurementMethodDetails": "Award procedure without prior publication of a call for competition",
        "coveredBy": [
            "GPA"
        ],
        "procurementMethodRationaleClassifications": [
            {
                "scheme": "TED_PT_AWARD_CONTRACT_WITHOUT_CALL",
                "id": "D_PROTECT_RIGHTS",
                "description": "The works, supplies or services can be provided only by a particular economic operator due to protection of exclusive rights, including intellectual property rights"
            }
        ],
        "procurementMethodRationale": "Regulation 32(2)(b)iii permits the award of a public contract by a negotiated procedure without prior publication where the works, supplies or services can only be supplied by a particular economic operator due to the protection of exclusive rights, including intellectual property rights. The absence of competition is not the result of an artificial narrowing down of the parameters of the procurement. The Western Health and Social Care Trust requires the purchase of RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets, SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300 mg in 2mLInjections which are subject to patent protection / Sole MA Holder and consequently no reasonable alternative of substitute exists."
    },
    "awards": [
        {
            "id": "027072-2024-WT2024-11, WT2024-12, WT2024-13-1",
            "relatedLots": [
                "1"
            ],
            "title": "NOVARTIS PHARMACEUTICALS UK LTD (WT) - WT2024-11, WT2024-12, WT2024-13 - RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets, SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300 mg in 2mLInjections",
            "status": "active",
            "suppliers": [
                {
                    "id": "GB-COH-00119006",
                    "name": "NOVARTIS PHARMACEUTICALS UK LIMITED"
                }
            ]
        }
    ],
    "parties": [
        {
            "id": "GB-FTS-54496",
            "name": "Western Health and Social Care Trust",
            "identifier": {
                "legalName": "Western Health and Social Care Trust",
                "noIdentifierRationale": "notOnAnyRegister"
            },
            "address": {
                "locality": "Londonderry",
                "region": "UKN0",
                "countryName": "United Kingdom"
            },
            "contactPoint": {
                "name": "Bronagh Hegarty",
                "telephone": "+44 2871345171",
                "email": "Bronagh.Hegarty@westerntrust.hscni.net"
            },
            "roles": [
                "reviewBody"
            ],
            "details": {
                "url": "https://westerntrust.hscni.net/",
                "classifications": [
                    {
                        "scheme": "TED_CA_TYPE",
                        "id": "BODY_PUBLIC",
                        "description": "Body governed by public law"
                    },
                    {
                        "scheme": "COFOG",
                        "id": "07",
                        "description": "Health"
                    }
                ]
            }
        },
        {
            "id": "GB-COH-00119006",
            "name": "NOVARTIS PHARMACEUTICALS UK LIMITED",
            "identifier": {
                "legalName": "NOVARTIS PHARMACEUTICALS UK LIMITED",
                "id": "00119006",
                "scheme": "GB-COH"
            },
            "address": {
                "streetAddress": "2nd Floor, The Westworks Building White City Place, 195 Wood Lane",
                "locality": "London",
                "region": "UKI",
                "postalCode": "W12 7FQ",
                "countryName": "United Kingdom"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large"
            }
        }
    ],
    "buyer": {
        "id": "GB-FTS-54496",
        "name": "Western Health and Social Care Trust"
    },
    "contracts": [
        {
            "id": "027072-2024-WT2024-11, WT2024-12, WT2024-13-1",
            "awardID": "027072-2024-WT2024-11, WT2024-12, WT2024-13-1",
            "title": "NOVARTIS PHARMACEUTICALS UK LTD (WT) - WT2024-11, WT2024-12, WT2024-13 - RIBOCICLIB [KISQALI] (AS SUCCINATE) 200 mg Tablets, SECUKINUMAB (COSENTYX) 150 mg in 1mL & 300 mg in 2mLInjections",
            "status": "active",
            "value": {
                "amount": 1532303.9,
                "currency": "GBP"
            },
            "dateSigned": "2024-08-16T00:00:00+01:00"
        }
    ],
    "bids": {
        "statistics": [
            {
                "id": "1",
                "measure": "bids",
                "relatedLot": "1",
                "value": 1
            }
        ]
    },
    "language": "en"
}